Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2013
05/30/2013US20130137728 Compositions and Methods for the Treatment of Degenerative Diseases
05/30/2013US20130137726 Conformationally restricted urea inhibitors of soluble epoxide hydrolase
05/30/2013US20130137723 Crystal of anti-bacterial compound
05/30/2013US20130137718 Process for the preparation of 2-(cyclohexylmethyl)-n--1,2,3,4-tetrahydroisoquinoline-7-sulfonamide
05/30/2013US20130137712 Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
05/30/2013US20130137704 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
05/30/2013US20130137703 Aminopyridine kinase inhibitors
05/30/2013US20130137700 Fused heterocyclic ring compound
05/30/2013US20130137695 Substituted 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase-1 inhibitors
05/30/2013US20130137688 Novel compounds
05/30/2013US20130137687 Novel pyrrolidine derivatives
05/30/2013US20130137686 Benzene, pyridine, and pyridazine derivatives
05/30/2013US20130137679 Novel Functionally Selective Ligands of Dopamine D2 Receptors
05/30/2013US20130137675 Heterocyclic compound and use thereof
05/30/2013US20130137674 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/30/2013US20130137673 Inhibitors of jak
05/30/2013US20130137671 Substituted Triazole Derivatives As Oxytocin Antagonists
05/30/2013US20130137665 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
05/30/2013US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same
05/30/2013US20130137660 Inhibitors of kinase activity
05/30/2013US20130137648 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/30/2013US20130137635 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
05/30/2013US20130137112 Dyes for analysis of protein aggregation
05/30/2013CA2856306A1 Selective kinase inhibitors
05/30/2013CA2856301A1 Pyrazine kinase inhibitors
05/30/2013CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
05/29/2013EP2597097A1 Substituted indoles, antiviral active component, method for producing and using same
05/29/2013EP2597088A1 P2x4 receptor antagonist
05/29/2013EP2597085A1 Organic compounds
05/29/2013EP2596793A1 Quinoline derivatives as PI3 kinase inhibitors
05/29/2013EP2595982A1 Protein kinase c inhibitors and uses thereof
05/29/2013EP2595981A1 Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests
05/29/2013EP2595967A2 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
05/29/2013EP2595965A1 Insecticidal triazines and pyrimidines
05/29/2013EP2595964A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them
05/29/2013EP2595620A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
05/29/2013EP2595485A1 Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders
05/29/2013EP2595484A1 Methods of use of cyclic amide derivatives to treat schizophrenia
05/29/2013EP2595483A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
05/29/2013DE19882402B9 Blockoligomere, enthaltend 1-Kohlenwasserstoffoxy-2,2,6,6-tetramethyl-4-piperidyl-Gruppen als Stabilisatoren für organische Materialien Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
05/29/2013DE19781981B3 Neue Pestizidkombination New pesticide combination
05/29/2013DE102011055815A1 Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung Carboxamide substituted heteroaryl-pyrazoles and their use
05/29/2013CN1747730B Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
05/29/2013CN103124729A Pharmaceutically active compounds as Axl inhibitors
05/29/2013CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
05/29/2013CN103124723A Novel microbiocides
05/29/2013CN103122001A Polo-like kinase inhibitors
05/29/2013CN103121996A Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
05/29/2013CN103121993A Salt of 2,6-dichloro-3-fluorophenyl derivative
05/29/2013CN103121992A New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
05/29/2013CN103121991A Aryl carboxylic acid imatinib derivative as well as preparation and application thereof
05/29/2013CN103121990A Cinnamyl amide imatinib ramification as well as preparation method and application thereof
05/29/2013CN103121973A Pyrimidine urea derivatives as kinase inhibitors
05/29/2013CN103121972A Pyrimidine urea derivatives as kinase inhibitors
05/29/2013CN103121970A Benzimidazole and derivative thereof, and medicinal composition and application thereof in preparation of antidepressant medicaments
05/29/2013CN103121969A Benzimidazole and derivative thereof, and medicinal composition and application thereof
05/29/2013CN102241670B Preparation method of high-purity chiral sulphoxide compound
05/29/2013CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
05/29/2013CN102206180B Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
05/29/2013CN102146056B N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives
05/29/2013CN102140092B Hydrate of ilaprazole salt, preparation method thereof and application thereof
05/29/2013CN101981013B Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
05/29/2013CN101687849B Crystalline forms of solvated ilaprazole
05/29/2013CN101628911B Antibiotic drug
05/29/2013CN101370804B Aminophenyl derivatives as novel inhibitors of histone deacetylase
05/28/2013US8450494 Disubstituted benzamide derivatives as glucokinase (GK) activators
05/28/2013US8450486 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
05/28/2013US8450484 TRPV4 antagonists
05/28/2013US8450478 Cyclic guanidine ionic liquid
05/28/2013US8450361 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
05/28/2013US8450344 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
05/28/2013US8450326 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
05/28/2013US8450307 Therapeutic agents, and methods of making and using the same
05/28/2013US8450304 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of CCR2
05/28/2013US8449936 Flavor molecules
05/28/2013CA2739883C Cyclohexane derivative and pharmaceutical use thereof
05/28/2013CA2735184C Heteroaryls amide derivatives and their use as glucokinase activators
05/28/2013CA2648236C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
05/28/2013CA2623958C 2-heteroaryl-substituted indole derivative
05/28/2013CA2577467C Hiv inhibiting 5-heterocyclyl pyrimidines
05/28/2013CA2570795C Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
05/28/2013CA2561066C Antiviral 4-aminocarbonylamino-substituted imidazole compounds
05/28/2013CA2547887C Protein modifier production inhibitor
05/28/2013CA2539823C Hemiasterlin derivatives and uses thereof
05/28/2013CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia
05/28/2013CA2485346C Human adam-10 inhibitors
05/23/2013WO2013074986A1 Inhibitors of c-jun-n-terminal kinase (jnk)
05/23/2013WO2013074641A1 Piperidinyl- substituted cyclic ureas as gpr119 modulators
05/23/2013WO2013074633A1 Uracil derivatives as axl and c-met kinase inhibitors
05/23/2013WO2013074388A1 Substituted cyclopropyl compounds useful as gpr119 agonists
05/23/2013WO2013073874A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same
05/23/2013WO2013073859A1 Novel organic electroluminescence compounds and organic electroluminescence device comprising the same
05/23/2013WO2013073577A1 Dihydroxy aromatic heterocyclic compound
05/23/2013WO2013072934A1 A novel process for the optical purification of proton pump inhibitors and pharmaceutically acceptable salts thereof.
05/23/2013WO2013072829A1 Novel nicotine derivatives
05/23/2013WO2013072825A1 Phtalazinone derivatives as mpegs -1 inhibitors
05/23/2013WO2013072758A1 Pyrimidine diol amides as sodium channel blockers
05/23/2013WO2013072705A1 Muscarinic m1 receptor agonists
05/23/2013WO2013072703A1 Antibacterial drug derivatives
05/23/2013WO2013072015A1 Morpholinyl benzotriazine for use in cancer therapy
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 1080